|
Otero MJ, Vera R, González-Pérez C, Ayala de la Peña F, Peñuelas Á, Quer N. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Farm Hosp. 2018 Nov 1;42(6):261-268. doi: 10.7399/fh.11132. PubMed PMID: 30381047.
AÑO: 2018
|
30381047
|
Jiménez-Fonseca P., Carmona-Bayonas A., Font C., Plasencia-Martínez J., Calvo-Temprano D., Otero R., Beato C., Biosca M., Sánchez M., Benegas M., Varona D., Faez L., Antonio M., de la Haba I., Madridano O., Solis M.P., Ramchandani A., Castañón E., Marchena P.J., Martín M., de la Peña F.A., Vicente V. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism. Clinical and Translational Oncology. 1 February 2018. 20:230-242. 10.1007/s12094-017-1713-3
AÑO: 2018; IF: 2.441
|
|
Gonzalez-Billalabeitia E, Castellano D, Sobrevilla N, Guma J, Hervas D, Luengo MI, Aparicio J, Sanchez-Muñoz A, Mellado B, Saenz A, Valverde C, Fernandez A, Margeli M, Duran I, Fernandez S, Sastre J, Ros S, Maroto P, Manneh R, Cerezuela P, Carmona-Bayonas A, Ayala de la Peña F, Luis Aguilar J, Rivera S, García Del Muro X, Germà-Lluch JR; Spanish Germ Cell Cancer Group/Grupo Germinal (SGCCG). Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients. J Natl Cancer Inst. 2017 Jan 25;109(4). doi: 10.1093/jnci/djw265. Print 2017 Jan. PubMed PMID: 28122896.
AÑO: 2017; IF: 11.238
|
|
Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, Zafra Poves M, García Hernández MR, Cuevas Tortosa E, Aliaga Baño Á, Castillo Guardiola V, Martínez Hernández P, Tovar Zapata I, Martínez Barba E, Ayala de la Peña F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x. PubMed PMID: 28477318.
AÑO: 2017; IF: 1.943
|
|
González A, Lluch A, Aba E, Albanell J, Antón A, Álvarez I, Ayala F, Barnadas A, Calvo L, Ciruelos E, Cortés J, de la Haba J, López-Vega JM, Martínez E, Muñoz M, Peláez I, Redondo A, Rodríguez Á, Rodríguez CA, Ruíz A, Llombart A. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM). Clin Transl Oncol. 2017 May;19(5):616-624. doi: 10.1007/s12094-016-1571-4. Epub 2016 Nov 16. Review. PubMed PMID: 27853985.
AÑO: 2017; IF: 2.392
|